Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMelrose Regulatory News (MRO)

Share Price Information for Melrose (MRO)

Share Price is delayed by 15 minutes
Get Live Data
458.90    -0.70 (-0.15%)
Bid:
458.80
Ask:
459.10
Spread: 0.30 (0.065%)
Market Cap: £5.72b
MRO Live PriceLast checked at - London Stock Exchange

Intraday Melrose Share Chart

Trading Update

18 Nov 2024 07:00

RNS Number : 5053M
Melrose Industries PLC
18 November 2024
 

18 November 2024

 

MELROSE INDUSTRIES PLC

 

Trading Update

Full year expectations unchanged

 

Melrose Industries PLC ("Melrose" or "the Group") announces the following trading update for the four months from 1 July 2024 to 31 October 2024 ("the Period"). All numbers are calculated at constant currency1.

 

Revenue was up 7%2 on the same period in 2023, with Engines, up 17%3, showing strong progress driven by aftermarket revenues, and Structures growing at 1%2,3, impacted by well-publicised OE volume reductions and previously announced customer destocking. We continue to partner closely with our major customers to execute efficiently on production schedules, whilst our internal business improvement actions progress as planned. As a result, adjusted4 operating profit continues to grow on the prior year, in line with our expectations.

 

End market demand continues to be positive, and our full year expectations remain unchanged.

 

Engines

 

The Engines division's revenue performance continues to be driven by our aftermarket business, which is up 32% versus prior year with a particularly strong contribution from defence. OE volume growth remains constrained by industry-wide supply chain issues. Looking ahead, the division is well placed to meet the ongoing industry ramp-up from its established positions as well as through new technologies.

 

Structures

 

Revenue in Structures, as previously highlighted, continues to reflect the planned exit of non-core work, customer destocking and industry-wide supply chain challenges affecting OE production rates. Defence repricing and business improvement actions, which are focused on this division, are coming through as planned. Restructuring programmes are on track and are nearing completion, which will result in a significant reduction in associated cash spend in 2025.

 

Outlook

 

As we progress through the second half, the Group's full year expectations are unchanged with adjusted4 operating profit at £550 million to £570 million5. Net debt4 is also anticipated to end the year in line with current expectations.

 

In 2025, despite continued supply chain challenges, we expect to make strong trading progress and we are on track to deliver our adjusted4 operating profit target of £700 million1,5. This performance is expected to be led by the strong aftermarket performance in our Engines division offsetting OE volume constraints. 

 

Importantly, the Group expects its cash flow position to improve significantly next year and to deliver substantial free cash flow in 2025 (post interest and tax). The Group's cash flow is poised to grow materially beyond this as a result of the completion of our restructuring programmes, the resolution of the GTF powder metal issue, all RRSPs6 generating cash and the continuing growth of the Group's profits.

 

The Group will provide longer term financial targets for the period beyond 2025 at its full year results on 6 March 2025.

 

 

Peter Dilnot, Chief Executive Officer of Melrose said:

 

"It's encouraging that we remain on track to deliver on our full year expectations, despite the industry-wide supply chain challenges. This reflects the strength of our businesses and the balanced position we have with our aftermarket offsetting original equipment headwinds. As we move into 2025, we enter a period of significant and sustained growth in our cash flow for many years ahead. I am confident that Melrose's established capabilities, technology leadership, and unique position on the world's leading aircraft and engines will create substantial value in the future."

 

 

Enquiries:

 

Investor Relations: Chris Dyett +44 (0) 7974 974690, ir@melroseplc.net

 

Media: Andrew Porter +44 (0) 207 404 5959, melrose@brunswickgroup.com

 

 

 

1 - Provided at a foreign exchange rate of USD 1.25: £1

2 - Growth rates are adjusted for disposals made in the first half of 2024

3 - On a like-for-like basis adjusting for a transfer of business between divisions

4 - Described in the glossary to the Melrose Industries PLC Interim Financial Statements and considered by the Board to be a key measure of performance

5 - Pre-plc costs

6 - Risk and Revenue Sharing Partnerships. Further details on RRSPs can be found on the Melrose plc website.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTQKPBDOBDDQDD
Date   Source Headline
1st Jun 202211:30 amRNSDirector/PDMR Shareholding
5th May 20224:09 pmRNSResult of AGM
5th May 20227:00 amRNSTrading Statement
7th Apr 20224:16 pmRNSDirector/PDMR Shareholding
31st Mar 20224:30 pmRNSNotice of AGM
25th Mar 20224:01 pmRNSStandard annual confirmation of post-offer
24th Mar 20224:33 pmRNSTR-1: Standard notification of major holdings
7th Mar 202211:20 amRNSDirector/PDMR Shareholding
3rd Mar 20222:10 pmRNSDirector/PDMR Shareholding
3rd Mar 20227:00 amRNSFinal Results
1st Mar 20222:45 pmRNSTR-1: Standard notification of major holdings
31st Dec 20218:27 amRNSDirector/PDMR Shareholding
10th Dec 20214:00 pmRNSDirector/PDMR Shareholding
2nd Nov 20213:24 pmRNSTR-1: Standard notification of major holdings
2nd Nov 20217:30 amRNSDirector Declaration
1st Nov 20218:00 amEQSEdison Investment Research Limited: Melrose Industries (MRO): Initiation - A proven, high-value creation model
25th Oct 20213:05 pmRNSDirector/PDMR Shareholding
22nd Oct 20215:00 pmRNSDirector/PDMR Shareholding
21st Oct 20213:50 pmRNSTR-1:Standard form notification of major holdings
8th Oct 20213:00 pmRNSTR-1:Standard form notification of major holdings
5th Oct 20217:00 amRNSTrading Statement
1st Oct 20214:30 pmRNSTR-1: Notification of major holdings
20th Sep 20215:20 pmRNSTR-1 Notification of major interest in shares
2nd Sep 20217:00 amRNSHalf-year Report
31st Aug 20217:00 amRNSReturn of Capital and Total Voting Rights
18th Aug 20215:00 pmRNSReturn of Capital and Total Voting Rights
30th Jul 20212:05 pmGNWForm 8.3 - Nortonlifelock Inc
9th Jul 202110:54 amRNSResults of General Meeting
24th Jun 20213:44 pmRNSDirector/PDMR Shareholding
22nd Jun 20213:31 pmRNSPosting of Circular and Notice of General Meeting
22nd Jun 20217:00 amRNSAir Management Disposal and Return of Capital
28th May 20214:00 pmRNSDirector/PDMR Shareholding
19th May 20214:48 pmRNSCapital Markets Event
6th May 20211:45 pmRNSResults of GM and AGM
6th May 20217:00 amRNSTrading Statement AGM
20th Apr 20213:34 pmRNSPosting of Circular and Notice of General Meeting
19th Apr 20217:00 amRNSProposed Disposal of Nortek Air Management
9th Apr 20217:00 amRNSAppointment of Non-Executive Directors
31st Mar 20214:30 pmRNSAnnual Financial Report
26th Mar 20215:00 pmRNSStandard annual confirmation of POUs
4th Mar 20214:04 pmRNSDirector/PDMR Shareholding
4th Mar 20217:00 amRNSFinal Results
21st Jan 20214:45 pmRNSResult of Meeting
4th Jan 20217:00 amRNSAppointment of Executive Director
29th Dec 202012:30 pmRNSPosting of Circular and Notice of General Meeting
8th Dec 20204:05 pmRNSHolding(s) in Company
25th Nov 20207:00 amRNSTrading Statement
25th Sep 20209:51 amRNSDirector/PDMR Shareholding
3rd Sep 20207:00 amRNSHalf-year Report
4th Aug 20207:00 amRNSFinancing Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.